Mycobacterium avium (Mav) complex (MAC) are characterized as non-tuberculosis 2 3 3 2 form of single nucleotide polymorphisms (SNPs), suggesting that Mav accumulates mutations at 3 3 high rates during persistent infections. Infection of murine macrophages and mice with sequential 3 4 isolates from patients showed a tendency towards increased persistence and down-regulation of 3 5 inflammatory cytokines by host-adapted Mav strains. The study revealed rapid genetic evolution 3 6 of Mav in chronically infected patients accompanied with change in virulence properties of the 3 7 sequential mycobacterial isolates. 3 8 IMPORTANCE 3 9 MAC are a group of opportunistic pathogens, consisting of Mav and M. intracellulare species. 4 0 Mav is found ubiquitously in the environment. In Mav infected individuals, Mav has been known 4 1 to persist for long periods of time, and anti-mycobacterial drugs are unable to effectively clear the 4 2
seen in . This is probably a consequence of the variety of niches that Mav species 7 8 occupy (such as soil, fresh water, showerheads etc.), and also indicates that Mav may be more revealed that a putative prophage (MAV0799-MAV0845) appears to be deleted in 13.1 and 13.2, 1 5 0 but not 13.3 and 13.4. These observations together indicate the presence of 2 subtypes that may 1 5 1 have originated within patient 13. Due to lack of multiple samples at each time point, it is 1 5 2 difficult to further substantiate this observation. Similar analysis was performed for patients 4 and 1 5 3 9. For patient 9, the SNPs did not change with respect to Mav 104, however for patient 4, 4 1 5 4 mutations now appeared to associate with 4.1 instead of 4.2-4.6 (Table S3 ). This suggests that facilitates intracellular replication of Mav in human primary macrophages (28) (29) (30) . We therefore 1 7 7
performed a broad systematic screen on the early expression of inflammatory genes to identify BMDMs were infected with the first and the last clinical isolates of patient 9 at a MOI of 10 for 6 1 8 0 hours. Genes were identified and plotted that were differentially expressed (at least two-fold 1 8 1 induced or repressed) in macrophages infected with the last compared to the first isolate ( Fig.S3 ). The analysis revealed down-regulation of many pro-inflammatory cytokines and we decided to 1 8 3 measure protein levels of two of them, IL-6 and IL-1β, from supernatants of BMDMs infected 1 8 4 with all isolates from patient 4, 9 and 13 ( Fig. 4a-b ). IL-1β secretion was low and highly variable 1 8 5 for all strains, whereas IL-6 secretion was more potently induced. As the gene expression data 1 8 6 indicated, we observe that despite an increased bacterial load in the macrophages infected with 1 8 7 the final isolates of patient 9 and 13, the IL-6 levels were lower than from supernatants of 1 8 8 macrophages infected with the first isolates. These results are in line with previous studies (31), 1 8 9 and the reduced inflammation may facilitate intracellular survival (Fig. 3 ). However, patient 4 1 9 0 isolates did not show a similar reduction in cytokine production and confirmed the level of infection, we measured the number of bacteria from both spleen and liver of mice ( Fig. 5a and b 1 9 8 respectively). Overall, the bacterial loads were constant or slightly increasing over time for most 1 9 9 isolates in both liver and spleen. For patient 9, the only significant difference was seen in the liver at day 30 p.i , where there was 2 0 1 an increase in CFU for the first isolate when compared to the last isolates (9.5, 9.6) (p<0.05).
0 2
This is incongruent with our observations in macrophage infections ( Fig. 3b-c ). However, the in 2 0 3 vivo data suggests no overall difference in virulence between the three isolates from patient 9( infectivity that we made in macrophages (Fig, 3b, c) . Throughout infection, we found 2 0 6 significantly increased bacterial loads in liver and spleen from mice infected with the last isolate, 2 0 7 13.4, compared to 13.1 and 13.2 ( Fig. 5a and b, right), suggesting a gain in virulence over time. At day 70, spleen size increased substantially in mice infected with isolates 13.2 and 13.4 2 0 9 compared to 13.1, and the color of the 13.4 spleens was strikingly pale when compared to the 2 1 0 other spleens ( Fig. 5c , upper row).
1 1
On further histological examination of spleens on day 70 p.i. (Fig. 5c , middle row), we 2 1 2 observed that the structure of the 13.4 spleens was almost replaced by coalescing granulomas. In 2 1 3 contrast, smaller amounts of single small or medium sized granulomas, in part coalescing for 2 1 4 13.2 spleens, were present in 13.1 and 13.2 spleens on day 70 p.i. Myeloid precursor cells and 2 1 5 megakaryocytes were found in all affected spleens, indicating extra medullary hematopoiesis. A 2 1 6 similar pattern of granulomatous infiltration was seen in liver sections on day 70 p.i. (Fig. 5c , 2 1 7 lower row), however the distinction between normal tissue and granulomas was less obvious than 2 1 8 in the spleen. Infection with the 13.4 isolate resulted in replacement of much of the normal liver 2 1 9 tissue with sheets of granulomas. The granulomas were sparse and mostly separated for 13.1, the 2 2 0 1 granulomas were moderate in number for 13.2 but starting to coalesce. It is important to note that 2 2 1 though 13.1 showed impaired growth in vitro, in vivo it still managed to survive, albeit poorly 2 2 2 when compared to 13.4. Taken together our data suggest that the Mav isolated from patient 13 2 2 3 changed properties over the course of infection in the patient and increased its ability to survive. Finally we investigated cytokine levels in organ homogenates from infected mice. The decrease 2 2 5 in level of IL-6 and IL-1β observed in macrophages could not be observed in liver homogenates 2 2 6 where levels were steady over time and between isolates ( Fig. S4 ). isolates from patient 9 and 13.It has previously been demonstrated that Mav infections elicit a 2 2 9 CD4+ Th1 immune response, which is associated with resisting the spread of the pathogen (32, 2 3 0 33). In our study, we analyzed Mav-specific IFNγ or TNFα (effector cytokine) production from 2 3 1 CD4+ and CD8+ T cells that were isolated from spleens of infected mice (Fig. 6 ). We observed 2 3 2 that the frequency of both Mav-specific CD4+ and CD8+ T cells were high on day 15 p.i. and 2 3 3 rapidly decreased by day 30 for patient 9, and more gradually to day 70 p.i for patient 13. This was lower (<5%) than CD4+ T cells (20-40%) and did not change much over the course of 2 3 7 infection. In the current study, we evaluated the mutations acquired by Mav during persistent infection in 2 4 1 human patients and further tested the pathogenesis of these isolates in macrophages and mice. Within macrophages, the Mav isolates from patients 9 and 13 exhibited higher bacterial load and 2 4 3 1 2 down-regulated inflammatory cytokines. However, the last isolates from patient 13, but not 2 4 4 patient 9, showed increased survival in mice compared to the first isolate. Most intra-patient isolates showed similar PFGE profiles, suggesting persistent infection 2 4 6 with a single MAC strain. On WGS analysis, we found variable mutation rates in sequential 2 4 7 intra-patient isolates. If we compare strains from different patients our findings are in congruence 2 4 8 with previous studies, which have reported high genetic diversity between Mav isolates (34-36). The mutation rate observed for isolates within a patient, ranged between 2.4-12.3 SNP's per year, 2 5 0 which is comparatively higher than the mutation rate of ~0.5 SNP reported for Mtb isolates from is more malleable than that of Mtb, and more prone to variation, maybe due to influence from 2 5 3 host factors. In addition, we analyzed the patient isolates for SNPs in two ways, the first was to 2 5 4 use the first isolate sequence from each patient as the founder strain and tabulate the SNPs 2 5 5 present in the subsequent isolates (Table S2 ). For the second analysis, all isolates from patients 2 5 6 were treated as independent cultures and compared it to the reference strain Mav 104 as an out 2 5 7 group. For patients 4 and 13, in the second analysis, two sub clonal populations were uncovered 2 5 8 (Table S3 ), which could either be due to a microevolution of a single founder strain or mixed/re- results obtained, we speculate that a diverse milieu can lead to modifications in the immune- such as recombineering, will be required to test their role in survival.
This is the first study analyzing in-patient evolution of Mav infection in humans. A 3 2 1 possible limitation is that the cohort studied was small. In addition, only a single isolate was more statistical confidence to our findings and could give more evidence for evolution within the human infection, and observed surprisingly high mutation rates. In addition, the response of the 3 2 6
immune system to these clinical isolates was tested in macrophages and mice, demonstrating a which Mav employs to resist chemotherapy and thereby help to develop more effective treatment 3 3 0 strategies. suspension. These suspensions were further used either in in vitro or in vivo infections. DNA was extracted by the CTAB-lysozyme method (59). Samples were sequenced on an 3 5 6
Illumina HiSeq 2500 with a read length of 106 bp or an Illumina HiSeq 4000 with a read length Genome sequences were assembled by a comparative-assembly method (60). Reads were The sequence data for the clinical isolates has been uploaded to the NCBI Sequence Read
Archive under accession number SRP136774 and are available through the following links: All protocols on animal work were approved by the Norwegian National Animal Research 3 7 9
Authorities and carried out in accordance with Norwegian and European regulations and guidelines. C57BL/6 mice were bred in house and used at 6-8 weeks of age for experiments. Mav-specific T cell cytokine production 3 8 6
Splenocytes were isolated and prepared for flow cytometry as described in (33). Splenocytes 3 8 7
were stimulated overnight with clinical Mav isolates from patient 9 and 13 at a MOI of 1. Graph Pad Prism 5.0 (GraphPad Software, Inc. Mycobacterium avium isolates to grow well or poorly in murine macrophages resides in 4 5 4 their ability to induce secretion of tumor necrosis factor. Infect Immun. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and - to four strains of Mycobacterium avium that differ in their growth and persistence 5 1 3
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